Barry Ticho Stoke Therapeutics, Inc. (STOK) insider trading activity

Barry Ticho is CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc.. Currently has a direct ownership of 2,485 shares of STOK, which is worth approximately $30,416. The most recent transaction as insider was on Sep 03, 2024, when has been sold 10,000 shares (Common Stock) at a price of $15.17 per share, resulting in proceeds of $151,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.49K

0% 3M change

90.4% 12M change

Total Value Held $30,416

Barry Ticho Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Open market or private sale	$151,700 $15.17 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Aug 01 2024	SELL Open market or private sale	$145,800 $14.58 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Jul 01 2024	SELL Open market or private sale	$137,500 $13.75 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Jun 03 2024	SELL Open market or private sale	$155,000 $15.5 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
May 01 2024	SELL Open market or private sale	$113,699 $11.37 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 44.47%	12,485 Common Stock
Apr 01 2024	SELL Open market or private sale	$124,705 $13.23 p/Share	9,426 Reduced 79.14%	2,485 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$265 $0.6 p/Share	442 Added 3.58%	11,911 Common Stock
Mar 19 2024	SELL Open market or private sale	$25,107 $6.1 p/Share	4,116 Reduced 26.41%	11,469 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	13,100 Added 45.67%	15,585 Common Stock
Mar 01 2024	SELL Open market or private sale	$77,500 $7.75 p/Share	10,000 Reduced 80.1%	2,485 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$3,302 $0.6 p/Share	5,504 Added 30.6%	12,485 Common Stock
Feb 01 2024	SELL Open market or private sale	$48,000 $4.8 p/Share	10,000 Reduced 58.89%	6,981 Common Stock
Jan 02 2024	SELL Open market or private sale	$57,400 $5.74 p/Share	10,000 Reduced 37.06%	16,981 Common Stock
Jul 03 2023	SELL Open market or private sale	$159,000 $10.6 p/Share	15,000 Reduced 36.68%	25,895 Common Stock
Jun 01 2023	SELL Open market or private sale	$166,950 $11.13 p/Share	15,000 Reduced 26.84%	40,895 Common Stock
May 04 2023	SELL Open market or private sale	$6,530 $10.0 p/Share	653 Reduced 1.15%	55,895 Common Stock
May 03 2023	SELL Open market or private sale	$250,427 $10.14 p/Share	24,697 Reduced 30.4%	56,548 Common Stock
May 02 2023	SELL Open market or private sale	$55,130 $10.0 p/Share	5,513 Reduced 6.35%	81,245 Common Stock
May 01 2023	SELL Open market or private sale	$249,670 $10.0 p/Share	24,967 Reduced 22.35%	86,758 Common Stock
Feb 06 2023	SELL Open market or private sale	$92,534 $10.02 p/Share	9,235 Reduced 7.63%	111,725 Common Stock

Barry Ticho

CHIEF MEDICAL OFFICER

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK

Account